Previously, we showed that MCF7 human breast carcinoma cells are susceptible to p53-mediated ferroptosis11 but, owing to a lack of ACSL4 expression, they are resistant to ferroptosis induced by either direct (e.g., RSL−3) or indirect (erastin) GPX4 inhibitors11,20. This evidence concerns the gene TP53 and breast carcinoma.